Table S3. Distribution of tumor markers in different stages of NSCLC and NEC.
Variable | Median | Cut-off | |
---|---|---|---|
NSCLC | NEC | ||
ProGRP (ng/L) | |||
I | 35.5 | 125.4 | 56.0 |
II | 35.3 | 183.8 | 54.0 |
I–II | 35.0 | 144.6 | 54.0 |
III | 35.0 | 559.1 | 64.0 |
IV | 34.5 | 1,294.2 | 99.0 |
NSE (µg/L) | |||
I | 11.7 | 14.0 | 13.0 |
II | 13.0 | 16.5 | 16.0 |
III | 13.5 | 28.5 | 18.0 |
IV | 14.8 | 52.2 | 26.0 |
NSCLC, non-small cell lung cancer; NEC, neuro-endocrine carcinoma; ProGRP, roles of gastrin-releasing peptide; NSE, neuron-specific enolase.